Paul Grof, MD, FRCPC Endorses Healthcare Practitioner Access to Psilocybin for Professional Training - TheraPsil
TheraPsil presents a discussion of psilocybin access for healthcare practitioner training, centered on the need for therapist familiarity with non-ordinary states of consciousness. The page includes background on TheraPsil’s training approach and a letter of support from Paul Grof, MD, FRCPC.
Provider
Details
Enrollment
Course Overview
This course page outlines TheraPsil’s rationale for healthcare practitioner access to psilocybin as part of professional training in psilocybin-assisted psychotherapy. It emphasizes that effective psychedelic-supported psychotherapy requires therapists to be prepared, familiar with non-ordinary states of consciousness, and able to support patients through preparation, facilitation, and integration. The source also describes TheraPsil’s broader training effort, including experiential learning, lectures, case studies, readings, and discussion. In this model, trainees may personally experience psilocybin mushrooms as part of their preparation to better understand the patient experience and the conditions needed for safe guidance. A letter of support from Paul Grof, MD, FRCPC is included, discussing historical training practices and the importance of supervised personal experience for therapists working with psychedelics. The page is intended for healthcare professionals and others involved in psilocybin-assisted psychotherapy training.
Who is this for?
Healthcare professionals involved in psilocybin-assisted psychotherapy, including doctors, therapists, clinical counselors, nurses, and social workers.
Prerequisites
None stated on the source page.
About the Provider
TheraPsil is a Canadian grassroots nonprofit advancing compassionate, legal access to psilocybin-assisted psychotherapy through clinician training, patient advocacy, and legal reform, having trained over 700 healthcare professionals since 2019. The organization assists Canadians in navigating Health Canada's Special Access Program, supports patient-rights litigation in Federal Court, and operates the PsilWell community-funded clinical trial exploring psilocybin-assisted therapy for general wellbeing.
View Therapsil profileCourse Details
- PricePrice on request
- FormatHybrid
- Lifecycle statusNo New Dates
- SkillsIntegrationPsychotherapyPsilocybin TherapyUnderstanding psilocybin-assisted psychotherapyPreparing to support non-ordinary states of consciousnessFacilitating patient sessionsRecognizing when to intervene during sessionsSupporting post-session integration